Value of regional lymphadenectomy in pancreatic cancer

HPB

Volumn 7, Issue 2, 2005, Pages 87-92

  Bassi, Claudio ^a   Salvia, R ^a   Butturini, G ^a   Marcucci, S ^a   Barugola, G ^a   Falconi, M ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; PANCREAS CANCER; PANCREATICODUODENECTOMY; PROGNOSIS; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TUMOR VOLUME;

EID: 20044363976     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1080/13651820510028855     Document Type: Review

References (41)

1. Gudjonson B. Carcinoma of the pancreas: critical analysis of costs, results of resections and the need of standardized reporting. J Am Coll Surg 1995;181:483-503.
2. Dervenis C, Bassi C. Pancreatic Tumors. Stutgard: Thieme-Verlag; 2000.
3. Neoptolemos JP, Dunn JA, Stocken D, Almond J, Link K, Beger H, Bassi C, Falconi M, Pederzoli P, Dervenis C, et al., for the members of the European Study Group for Pancreatic Cancer. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomized controlled trial. The Lancet 2001;358:1576-85.
4. Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, Beger H, Fernandez-Cruz L, Dervenis C, Lacaine F, et al. European Study Group for Pancreatic Cancer. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004;350: 1200-10.
5. Nagakawa T, Kobayashi H, Ueno K, Ohta T, Kayahara M, Mori K, Nakano T, Takeda T, Konishi I, Miyazaki I. The pattern of lymph node involvement in carcinoma of the head of the pancreas. Int J Pancreatol 1993;13:15-22.
6. Japan Pancreas Society. Classification of Pancreatic Carcinoma. (English edition). Tokio: Kanehara; 1996.
7. Kockerling F, Kessler H, Hermanek P, Gall FP. The role of lymph node dissection in the treatment of ductal carcinoma of the pancreas. In: Beger HG, Buchler M, Schoenberg MH, editors. Cancer of The Pancreas. Ulm, Germany: Universitätsverlag Ulm, 1996. p 403-08.
8. Yeo CJ, Cameron JL, Lillemoe KD, Sitzmann JV, Hruban RH, Goodman SN, Dooley WC, Coleman J, Pitt HA. Pancreaticoduodenectomy for cancer of the head of the pancreas. Ann Surg 1995;221:721-33.
9. Cubilla AL, Fitzgerald PJ. Surgical Pathology of tumors of esocrine pancreas. In: Moossa AR, editor. Tumors of the Pancreas. Baltimore: Williams & Wilkins; 1980. p 159-93.
10. Nagakawa T, Kobayashi H, Ueno T, Kayahara I, Miyazaki I. Clinical study on lymphatic flow to the paraortic lymph nodes in carcinoma of the head of the pancreas. Cancer 1994; 73:1155-62.
11. Kawarada Y, Yanigisawa K, Isaji S, Mizumoto R. The prevalence of pancreatic cancer lymph node metastasis in Japan and pancreatic cancer categories. Int J Pancreatol 1994;16: 101-04.
12. Bassi C, Falconi M, Talamini G, Salvia R, Caldiron E, De Santis L, Bonora A, Butturini G, Sartori N, Procacci C, et al. Prospective study of the detection and treatment of Small tumors of the head of the pancreas. J Hep Bil Pancr Surg 1995;2:347-51.
13. Cameron JP, Pitt HA, Yeo CJ, Lillemoe KD, Kaufmann HS, Coleman J. One hundred and forty five consecutive pancreaticoduodenectomies without mortality. Ann Surg 1993;217:430-8.
14. Klempnauer J, Ridder GJ, Bektas H, Pichmayr R. Surgery for exocrine pancreatic cancer: who are the five and ten year survivors? Oncology 1995;52:353-9.
15. Isikawa O, Ohhigashi K, Sasaky J, et al. Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of pancreas head. Ann Surg 1988;208:215-20.
16. Nagakawa T, Konishi I, Ohta T, et al. The results and problems of extensive radical surgery for carcinoma of the head of the pancreas. Jpn J Surg 1991;21:262-7.
17. Osaki H. Modern surgical treatment of pancreatic cancer. Int J Pancreatol 1994;16:121-9.
18. Henne-Bruns D, Vogel I, Lunges J, Kloppel G, Kremer B. Surgery for ductal adenocarcinoma of the pancreatic head: staging, complications, and survival after regional versus extended lyphadenectomy. World J Surg 2000;24: 595-601.
19. Mcfadden DW, Reber HA. Cancer of the pancreas: radical resection-supporting view. Adv Surg 1994;27:257-72.
20. Fortner JG. Regional resection of cancer of the pancreas: a new surgical approach. Surgery 1973;73:307-20.
21. Manabe T, Ohshio G, Baba N, Miyashita T, Asano N, Tamura K, Yamaki K, Nonaka A, Tobe T. Radical pancreatectomy for ductal cell carcinoma of the head of the pancreas. Cancer 1989;64:1132-7.
22. Sindelar WF. Clinical experience with regional pancreatectomy for adenocarcinoma of the pancreas. Arch Surg 1989;124: 127-32.
23. Pedrazzoli S, Di Carlo V, Dionigi R, Mosca F, Pederzoli P, Pasquali C, Klöppel G, Dheane K, Michelassi F, Sperti C, et al. Standard Versus Extended Lymphadenectomy Associated with Pancreatoduodenectomy in the Surgical Treatment of Adenocarcinoma of the Head of the Pancreas: a multicenter, prospective, randomized study. Ann Surg 1998;228: 508-17.
24. Yeo CJ, Cameron JL, Sohn TA, Coleman J, Sauter PK, Hruban RH, Pitt HA, Lillemoe KD. Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg 1999;229:613-22.
25. Farnell MB. Presentation to The Pancreas Cancer Conference. Tirrenia, Italy, April 2004.
26. Fuhrman GM, Leach SD, Staley CA, Cusak JC, Charnsangavej C, Cleary KR, El Naggar AK, Fenoglio CJ, Lee JE, Evans DB. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group. Ann Surg 1996;223:154-62.
27. Harrison LE, Brenner MF. Portal vein involvement in pancreatic cancer: a sign of unresectabily? Adv Surg 1997; 31:375-94.
28. Van Green RC, Ten Kate FJ, De Wit LT, Van Gulik TM, Obertop H, Gouma DJ. Segmental resection and wedge excision of the portal or superior mesenteric vein during pancreatoduodenectomy. Surgery 2001;129:158-63.
29. Hartel M, Niedergethmann M, Farag-Soliman M, Sturm JW, Ricther A, Trede M, Post S. Benefit of venous resection for ductal adenocarcinoma of the pancreatic head. Eur J Surg 2002;168:707-12.
30. Keck H, Knoop M, Langrehr JM, Henneken V, Neuhaus P. [Extended partial Kausch-Whipple duodenopancreatectomy by resection of tumor infiltrated vascular segments]. Zentralbl Chir 1995;120:809-14.
31. Klempnauer J, Ridder GJ, Bektas H, Pichlmayr R. Extended resections of ductal pancreatic cancer-impact on operative risk and prognosis. Oncology 1996;53:4-53.
32. Roder JD, Stein HJ, Siewert JR. Carcinoma of rhe periampullaryregion: who benefits from portal vein resection? Am J Surg 1996,171:170-4.
33. Shibata C. Kobari M, Tsuchiya T, Arai K, Anzai R, Takahashi M, Uzuki M, Sawai T, Yamazaki T. Pancreatectomy combined with superior mesenteric-portal vein resection for adenocarcinoma in pancreas. World J Surg 2001,25:1002-05.
34. Takahashi S, Ogata Y, Tsuzuki T. Combined resection of the pancreas and portal vein for pancreatic cancer. Br J Surg 1994,81:1190-3.
35. Yeo CJ, Cameron JL, Lillemoe KD, Sohn TA, Campbell KA, Sauter PK, Coleman J, Abrams RA, Hruban RH. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 2002,236: 355-66.
36. Nguyen TC, Sohn TA, Cameron JL, Lillemoe KD, Campbell KA, Coleman J, Sauter PK, Abrams RA, Hruban RH, Yeo CJ. Standard versus Radical pancreaticoduodenectomy for periampullary adenocarcinoma: a prospective, randomized trial evaluating quality of life in pancreaticoduodenectomy survivors. J Gastrointest Surg 2003,7:1-9.
37. Falconi M, Mantovani W, Betrini R, Talamini G, Bassi C, Cascinu S, Oliani C, Pederzoli P. Carcinoma of pancreatic body and tail: are there improvements in diagnosis and treatment modalities over the past decade? Dig Liver Dis 2003; 35:421-7.
38. Neoptolemos JP, Moffitt DD, Dunn JA, Almond J, Beger HG, Pederzoli P, Bassi C, Dervenis C, Femandez-Cruz L, Lacaine F, et al., for the members of the European Study Group for Pancreatic Cancer. The influence of resection margin on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy within the ESPAC-1 randomized controlled trial. Ann Surg 2001,234: 758-68.
39. Capussotti L, Massucco P, Ribero D, Vigano L, Muratore A, Clgaro C. Extended limphadenectomy and vein resection for pancreatic cancer: outcomes and implications for therapy. Arch Surg 2003,138:1316-22.
40. Pedrazzoli S, Beger HG, Obertop H, Andren-Sandberg A, Femandez-Cruz L, Henne-Bruns D, Luttges J, Neoptolemos J. A surgical and pathological based classification of resective treatment of pancreatic cancer. Summary of an international workshop on surgical procedures in pancreatic cancer. Dig Surg 1999,16:337-45.
41. Satake K, Nishivaki H, Yokomatsu H, Kim k, Haku A, Umeyama K, Miyaazaki I. Surgical curability and prognosis for standard versus extended resection for T1 carcinoma of the pancreas. Surg Gynecol Obstet 1992,175:259-65.